Table I.
Changes in the levels of uric acid in the rats of the different groups (mean ± SD).
Group | YEP + OA | Rosuvastatin (mg/kg/day) | Allopurinol (mg/kg/day) | Uric acid (μmol/l) | |||
---|---|---|---|---|---|---|---|
| |||||||
Week 0 | Week 2 | Week 4 | Week 6 | ||||
Blank control | - | - | - | 43.99±0.59 | 49.50±2.64cegik | 45.31±1.66cdgi | 45.14±0.89cfi |
Model | ✓ | - | - | 46.71±3.88 | 248.00±8.18begik | 352.25±5.35begik | 216.00±6.15begik |
Rosuvastatin | ✓ | 2.50 | - | 43.29±0.90 | 124.75±16.79bc | 118.50±4.65begik | 89.75±2.04bcegk |
✓ | 5.00 | - | 44.63±1.09 | 129.00±5.05bc | 100.50±1.72begik | 62.25±6.20acdhj | |
✓ | 10.00 | - | 42.28±0.61 | 112.75±13.89bc | 67.00±10.27ace | 41.75±4.76cfi | |
Allopurinol | ✓ | - | 53.75 | 40.69±5.51 | 103.75±10.03bc | 59.25±2.86ace | 44.75±4.32cfi |
P<0.05 and
P<0.01, vs. blank control group;
P<0.01, vs. model group;
P<0.05 and
P<0.01, vs. 10 mg/kg/day rosuvastatin group;
P<0.05 and
P<0.01, vs. 5 mg/kg/day rosuvastatin group;
P<0.05 and
P<0.01, vs. 2.5 mg/kg/day rosuvastatin group;
P<0.05 and
P<0.01, vs. allopurinol group.
YEP, yeast extract powder; OA, oxonic acid.